Browse all clinical trials

Sponsor Updatedsort icon
Phase III An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation Forest Laboratories 2009-05-20
Phase III Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection Bristol-Myers Squibb 2009-05-20
Phase II Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-Positive (ER+/PR+) or Her2/Neu-Positive (Her2/Neu+)Breast Cancer Bristol-Myers Squibb 2009-05-20
Phase III Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC) Genentech 2009-05-20
Phase III Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) National Cancer Institute (NCI) 2009-05-20
Phase II A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer Bristol-Myers Squibb 2009-05-20
Growth Hormone as a Determinant of Weight Regulation. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2009-05-20
An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection Bristol-Myers Squibb 2009-05-20
Phase III Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma Bristol-Myers Squibb 2009-05-20
Phase II Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types Bristol-Myers Squibb 2009-05-20
Phase IV Suboptimal Responders to Adefovir Switching to Entecavir Bristol-Myers Squibb 2009-05-20
Phase III Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung Disease Inspire Pharmaceuticals 2009-05-20
Phase III Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation Bristol-Myers Squibb 2009-05-20
A Low Glycemic Load Diet During Pregnancy in Overweight Women National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2009-05-20
Phase IV Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115AM1)(COMPLETED) Schering-Plough 2009-05-20
Phase III A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise Bristol-Myers Squibb 2009-05-20
Phase III Vincristine, Carboplatin, and Etoposide or Observation Only in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Retinoblastoma National Cancer Institute (NCI) 2009-05-20
Phase II Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures Pfizer 2009-05-20
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection Bristol-Myers Squibb 2009-05-20
Phase I 17-N-Allylamino-17-Demethoxygeldanamycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes National Cancer Institute (NCI) 2009-05-20
Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer Metastases M.D. Anderson Cancer Center 2009-05-20
Phase I Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women Bristol-Myers Squibb 2009-05-20
Phase I A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung Cancer Bristol-Myers Squibb 2009-05-20
Phase II A Trial of 2 Schedules of Ixabepilone Plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast Cancer Bristol-Myers Squibb 2009-05-20
Phase I Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer National Cancer Institute (NCI) 2009-05-20